TLR9 -1486C/T polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation.
Conclusion: TLR9 -1486C/T might help to preoperatively identify patients at low risk of post-transplant HCC recurrence.
PMID: 31317790 [PubMed - as supplied by publisher]
Source: Future Medicine: Biomarkers in Medicine - Category: Internal Medicine Tags: Biomark Med Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Internal Medicine | Liver | Liver Cancer | Liver Transplant | Transplant Surgery | Transplants | Urology & Nephrology